Chugai Pharmaceutical Co., Ltd.
CHGCF
Updated: 24/09/2026, 15:34:12
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
No summaries found.
- Share price
- $42.57
- Market cap
- $70.07B
- Exchange
- OTC
- Currency
- USD
- CEO
- Osamu Okuda
- Employees
- 7,872
- IPO date
- 03/08/2012
- Beta
- 0.54
- Last dividend
- $0.00
- Day range
- $41.80 – $42.57
- 52-week range
- $34.79 – $68.08
- 1-day performance
- -1.49%
- 1-year performance
- 22.38%
- Current drawdown (1Y)
- -37.46%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- JP3519400000
- Created
- 07/12/2025, 03:17:17
- Last update
- 24/09/2026, 15:34:12
Track Chugai Pharmaceutical Co., Ltd. with an AI analyst
See which prediction-market events move CHGCF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.